Dynavax Technologies Corporation (DVAX) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Latest reported DVAX revenue for 2024-12-31 was $277.2M. Net income was $27.3M. Revenue was up 19.4% from 2023-12-31 to 2024-12-31. DVAX currently screens at market cap $1.82B.
Use this DVAX page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the DVAX quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the DVAX SEC filings page. Lician reads the product cache first so this HTML stays unique to Dynavax Technologies Corporation even when a live quote feed is slow.
Latest cached year on this hub. Full DVAX income, balance, and cash tables.